Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
This study has been completed.
First Received: March 15, 2003   Last Updated: August 4, 2009   History of Changes
Sponsor: Avanir Pharmaceuticals
Information provided by: Avanir Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00056524
  Purpose

The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect (episodes of uncontrolled crying and/or laughter).


Condition Intervention Phase
Alzheimer's Disease
Stroke
Parkinson's Disease
Traumatic Brain Injury
Drug: AVP-923
Phase III

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Official Title: An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.

Resource links provided by NLM:


Further study details as provided by Avanir Pharmaceuticals:

Primary Outcome Measures:
  • emotional control

Estimated Enrollment: 600
Study Start Date: February 2003
Detailed Description:

This is an "open label" study which means there is no placebo group. Each subject enrolled into the study will receive AVP-923.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 to 75 years of age, inclusive
  • Clinical diagnosis of PBA (pseudobulbar affect)
  • If female, must not be pregnant or breast feeding

Exclusion Criteria:

  • Sensitivity to quinidine or any opiate drugs
  • Current or prior history of major psychiatric disturbance
  • Currently participated in a trial within the past 30 days
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00056524

  Hide Study Locations
Locations
United States, Arizona
Barrow Neurological Institute
Phoenix, Arizona, United States, 85013
United States, California
UCLA School of Medicine
Los Angeles, California, United States, 90095
UCSF
San Francisco, California, United States, 94117
Center for Neurologic Study
La Jolla, California, United States, 92037
United States, Connecticut
Research Center for Clinical Studies, Inc.
Darien, Connecticut, United States, 06820
United States, District of Columbia
George Washington University Medical Faculty Assoc.
Washington, District of Columbia, United States, 20037
United States, Florida
Neurological Associates
Ft. Lauderdale, Florida, United States, 33334
University of Miami Dept. of Neurology
Miami, Florida, United States, 33136
Renstar Medical Research
Plantation, Florida, United States, 33324
Suncoast Neuroscience Associates Inc.
St. Petersburg, Florida, United States, 33701
Tampa, Florida, United States, 33606
Allied Clinical Trials
Miami, Florida, United States, 33181
Miami Jewish Home & Hospital for the Aged
Miami, Florida, United States, 33137
United States, Georgia
Neurology & Headache Specialist of Atlanta, L.L.C.
Decatur, Georgia, United States, 30033
United States, Illinois
Consultants in Neurology LTD
Northbrook, Illinois, United States, 60062
United States, Montana
Advanced Neurology Specialists
Great Falls, Montana, United States, 59405
United States, Nebraska
Neurological Associates, P.C.
Lincoln, Nebraska, United States, 68506
United States, New York
Hospital for Joint Diseases MS Care Center
New York, New York, United States, 10003
SUNY Upstate Medical University
Syracuse, New York, United States, 13210
Upstate Clinical Research
Albany, New York, United States, 12205
DENT Neurologic Group L.L.P.
Amherst, New York, United States, 14266
United States, North Carolina
Raleigh Neurology Associates, PA
Raleigh, North Carolina, United States, 27607
Carolinas Medical Center
Charlotte, North Carolina, United States, 28203
United States, Ohio
NeuroCare Center, Inc.
Canton, Ohio, United States, 44718
MetroHealth Medical Center
Cleveland, Ohio, United States, 44109
University Memory and Aging Center
Cleveland, Ohio, United States, 44120
The Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
United States, Oklahoma
Clinical Pharmaceutical Trials, Inc.
Tulsa, Oklahoma, United States, 74104
United States, Pennsylvania
Lehigh Valley Neurosciences and Pain Research Center
Allentown, Pennsylvania, United States, 18103
Neurological Associates of Delaware Valley
Upland, Pennsylvania, United States, 19013
Penn Neurological Institute
Philadelphia, Pennsylvania, United States, 19107
Westmoreland Neurology
Greensburg, Pennsylvania, United States, 15601
MCP-Hahnemann University
Philadelphia, Pennsylvania, United States, 19107
Jenkintown, Pennsylvania, United States, 19046
United States, Texas
Methodist Neurological Institute
Houston, Texas, United States, 77030
Claghorn-Lesem Research Clinic
Bellaire, Texas, United States, 77401
United States, Vermont
Fletcher Allen Health Care
Burlington, Vermont, United States, 05401
United States, Washington
Neurology and Neurosurgery Associates of Tacoma
Tacoma, Washington, United States, 98405
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
Avanir Pharmaceuticals
  More Information

Additional Information:
No publications provided

Study ID Numbers: 02-AVR-107, AVP-923
Study First Received: March 15, 2003
Last Updated: August 4, 2009
ClinicalTrials.gov Identifier: NCT00056524     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Avanir Pharmaceuticals:
ALS
MS
CNS
AD
TBI
Dextromethorphan
IEED
Emotional

Additional relevant MeSH terms:
Craniocerebral Trauma
Alzheimer Disease
Nervous System Diseases
Basal Ganglia Diseases
Wounds and Injuries
Disorders of Environmental Origin
Central Nervous System Diseases
Trauma, Nervous System
Brain Diseases
Neurodegenerative Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Movement Disorders
Parkinson Disease
Mental Disorders
Parkinsonian Disorders
Brain Injuries
Dementia
Tauopathies

ClinicalTrials.gov processed this record on November 30, 2009